Navegar por autor "Gordillo, J."

Mostrando ítems 1-6 de 6

Efficacy and safety of tacrolimus in Crohn's disease: a nationwide, multi-centric study from GETECCU

2019- Rodriguez-Lago, I.; Castro-Poceiro, J.; Fernandez-Clotet, A.; Mesonero, F.; Lopez-Sanroman, A.; [et al.]
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

2022- Gutiérrez, A.; Zapater, P.; Ricart, E.; González-Vivó, M.; Gordillo, J.; [et al.]
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

2022- Chaparro, M.; Bastón Rey, Iria; Fernández Salgado, Estela; González García, J.; Ramos, L.; [et al.]
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

2022- Zabana, Y.; Marín-Jiménez, I.; Rodríguez-Lago, I.; Vera, I.; Martín-Arranz, M.D.; [et al.]
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII)

2022- Zabana, Y.; Marín-Jiménez, I.; Rodríguez-Lago, I.; Vera, I.; Martín-Arranz, M.D.; [et al.]
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab

2022- Chaparro, M.; Bastón Rey, Iria; Fernández Salgado, Estela; González García, J.; Ramos, L.; [et al.]